Sprachauswahl: PharmaLab Kongress - Deutschsprachige Version der WebsiteDE | PharmaLab Congress - Switch to the English version of the websiteEN

Live Online Conference: Alternative and Rapid Microbiological Methods

24 November 2021, 09.00 - 17.30 h CET

Objectives

This Live Online Conference will review the current knowledge about developments in modern microbiological methods and mycoplasma detection strategies for quality control in biopharmaceutical manufacturing.

This one-day Live Online Conference provides the opportunity to discuss the recent advances in the area of the newest technological developments as well as practical aspects and concerns of meeting the regulatory requirements. State-of-the-art presentations from authority speakers, as well as industrial and academic experts in the field of microbiological detection and identification and mycoplasmology with particular focus on the current methodologies their implementation and validation will provide an in-depth overview.

Background

The scientific progress in the field of cellular and molecular biotechnology led to a fast development of biopharmaceuticals, tissue engineered applications and advanced therapy medicinal products (ATMPs). Against this background, the safety of such new technologies, products and applications becomes more importance. One important topic in the focus of risk assessment and safety is the contamination with microorganisms and mycoplasmas and their detection, prevention and control.

Target Audience

This Live Online Conference is of interest to professionals from

  • Biotechnological & Biopharmaceutical Companies
  • Contract Service Laboratories
  • Academic Research Institutions and Organizations
  • Government Agencies
  • Cell Culture Collections
  • Supplier Detection Systems

with responsibilities in

  • Manufacturing
  • Quality Assurance
  • Quality Control
  • Regulatory Affairs
  • Research & Development
  • Process Development
  • Validation

Programme

The Journey of Implementing an Alternative Rapid Sterility Test
Dr Jonas van den Berg, Roche

Demonstrating an Approach to Rapid Microbiological Testing for Cell-based Therapies
Brice Chasey, CRL

A Look into Rapid Microbial Contamination Detection in Cell containing Samples
Johannes Oberdörfer, Boehringer Ingelheim
Stefan Gärtner, Labor LS

BFPC Rapid-C Projekt
Dr Wolfgang Eder, Roche
Ronny Zingre, MBV

Mycoplasma Testing – Evolution towards RtR at Janssen Biologics BV
Alex van den Meer, Janssen

Updates in Rapid Hybrid Mycoplasma Testing
Marleen Hoozemans, MSD

Application of Next Generation Sequencing for Microbial Identification, Typing and Profiling
Tara Cassidy/Dr Prasanna Khot, Charles River Laboratories

Colony Counters: How to Evaluate Vision Algorithm Performance
Dr David Jones, Rapid Micro Biosystems

Method Validation and Implementation of the GD for Performing of Environmental Controls in Sterile Production
Dr Hans-Joachim Anders, Novartis

Two Hours T2R - From Complex Sample Matrix to Direct Viability Count & Identification, Typing and Profiling |
Discussion of the GramRay Toolbox & Strategies
Dr Oliver Valet, mibiC

Vitek MS Prime: Innovation in MALDI-TOF MS - Next level experiences
Victoria Gerad, bioMérieux

Speakers

Dr Hans-Joachim Anders, Novartis, Switzerland
Teamlead Analytical Science and Technology Microbiology.

Tara Cassidy, Charles River Laboratories, Australia
Applications Development Specialist.

Brice Chasey, Charles River Laboratories, USA
Associate Director Product Management.

Dr Wolfgang Eder, Roche Diagnostics, Germany
Head of Global Functions Supply Chain IT.

Stefan Gärtner, Labor LS, Germany
Head of Department - Sterile Products Rapid and Alternative Methods.

Dr Victoria Gerad, bioMérieux
R&D biosciences director (VITEK MS, KM) and Microbial Identification Global Expert.

Marleen Hoozemans, MSD, The Netherlands
Specialist Microbiology.

Dr David Jones, Rapid Micro Biosystems, USA
Director Industry Affairs.

Dr Prasanna Khot, Charles River Laboratories, USA
Research and Development Manager.

Johannes Oberdörfer, Boehringer Ingelheim, Germany
Scientist Rapid Microbiology Methods.

Dr Oliver Valet, mibiC, Germany
Co-founder and Managing Director.

Dr Jonas van den Berg, Roche Diagnostics, Germany
Global Quality Control.

Alex van der Meer, Janssen Biologics, Netherlands
QC Technical Specialist Mycoplasma & PCR.

Ronny Zingre, MBV, Switzerland
CEO.